Experimental pancreatic cancer drug offers new hope in major trial
Key Points:
- An experimental drug for metastatic pancreatic cancer nearly doubled overall survival in a Phase 3 clinical trial, offering new hope for patients with one of the deadliest forms of cancer.
- The finding